Call for Abstract

The Scientific Committee of the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) invites you to submit your abstracts for Oral and / or Poster presentations at ASPIRE 2024. Please see submission guidelines below.

ABSTRACT THEMES

1. ART, Clinical 11. Gynaecology and Surgery
2. ART, Basic Research 12. Male Fertility
3. ART, Laboratory 13. Menopause
4. Contraception 14. Nursing
5. Counselling, Ethics and Psychosocial 15. Ovary and Ovarian Biology
6. Embryology 16. PCOS
7. Endocrinology, Clinical 17. Preimplantation Screening and Diagnosis
8. Endocrinology, Laboratory 18. Regenerative Medicine and Stem Cells
9. Female Infertility 19. Reproductive Genetics
10. Fertility Preservation 20. Uterine Disorders and Endometriosis

KEY DATES

Late-breaking Abstract Submission Deadline: 19 December 2023  Extended to 9 January 2024
Extended to 31 January 2024
Early Bird Registration Opens: 26 September 2023
Acceptance Results Notification: 5 February 2024
Registration Deadline for Abstract Presenters: 20 February 2024

ASPIRE ABSTRACT AWARDS

Best Oral Presentation Awards and Best Poster Presentation Awards will be granted in recognition for the outstanding research works. ASPIRE Young Investigator Awards will also be granted to support the quality researches in ART by the authors aged below 40 from Asia Pacific. View details on the awards Best oral and poster / YIA.

ABSTRACT SELECTION AND PRESENTATION

All abstracts will undergo review by a selected panel of experts. The Scientific Committee will determine whether abstracts will be accepted as oral or poster presentations with consideration to be given to the author’s preference. Submitting authors will be notified via e-mail by 5 February 2024 regarding the status of their abstract acceptance.

SUBMISSION GUIDELINES

Please prepare the following information for your abstract submission process:

  • Presenting Author’s and Co-authors’ Details.
  • Full First and Family Name(s).
  • Affiliation Details: department, institution / hospital, city, state (if relevant), country, email address.
  • Abstract Title: limited to 25 words in UPPER CASE.
  • Abstract text – limited to 300 words, including acknowledgements. We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.
  • Abstracts should clearly state:
    • Background and Aims
    • Methods
    • Results
    • Conclusions
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appear the first time.
  • Use generic names of drugs. Express numbers as numerals.
  • Abstract Themes: abstracts must be allocated to a specific category for the Scientific Program. You will need to select the category most suited to your abstract.
  • Tables – A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract. When including a table, it is recommended to save the table as an image (JPG format).
  • Graphs and Images – A maximum of 2 images can be included per abstract. The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel.
  • Graphs and images may be uploaded in JPG, PNG or GIF format only.

GENERAL POLICY AND REQUIREMENTS

  • Authors can submit and present up to 2 abstracts.
  • All abstracts must be original work and cannot be published or presented at any other congress prior to the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024).
  • All submissions must be completed via the ASPIRE 2024 Abstract submission portal by the announced deadline. Abstracts submitted via any other platform or after the announced deadline will NOT be accepted.
  • Abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.
  • The content of the submitted abstract cannot be modified or corrected after 31 January 2024 GMT+8 and abstract will be published exactly as submitted.
  • Abstract must contain sufficient information so that if published it will be a complete report independent of presentation. The text should not contain statements alluding to results or conclusions not presented within the text.
  • Submission acknowledges consent to publication of the abstract in the Congress proceedings publication.
  • The presenting author are required to complete their registration for the Congress by 20 February 2024 GMT+8 in order to ensure inclusion of the abstract in the Congress publications and be scheduled for presentation.

DISCLOSURE

Disclosure of financial relationships that the author(s) may have with the manufacturer/supplier of any commercial products or services related to the work, should be indicated in the appropriate box on the abstract form.